Scarica l'app Stockscreener
1.33
3.10%
0.04
Precedente Chiudi:
$1.29
Aprire:
$1.31
Volume 24 ore:
42,436
Relative Volume:
0.04
Capitalizzazione di mercato:
$5.98M
Reddito:
$9.37M
Utile/perdita netta:
$-8.45M
Rapporto P/E:
-1.642
EPS:
-0.81
Flusso di cassa netto:
$-7.27M
1 W Prestazione:
+9.02%
1M Prestazione:
-19.88%
6M Prestazione:
-86.96%
1 anno Prestazione:
-95.19%
Intervallo 1D:
$1.30
$1.3744
Intervallo di 1 settimana:
$1.2301
$1.47
Portata 52W:
$1.1101
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Confronta BIAF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.33 | 5.80M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
Why bioAffinity Technologies Inc. Equity Warrant stock appeals to dividend seekersPortfolio Value Report & Fast Entry Momentum Alerts - ulpravda.ru
Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growth2025 Key Lessons & Weekly Momentum Picks - ulpravda.ru
Will bioAffinity Technologies Inc. stock outperform tech sector in 2025Quarterly Growth Report & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Is bioAffinity Technologies Inc. Equity Warrant stock cheap compared to fundamentalsJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - ulpravda.ru
Will bioAffinity Technologies Inc. stock pay special dividendsJuly 2025 Sector Moves & Low Risk High Win Rate Picks - ulpravda.ru
Can bioAffinity Technologies Inc. stock maintain growth trajectoryWeekly Market Summary & Detailed Earnings Play Strategies - ulpravda.ru
Will bioAffinity Technologies Inc. stock attract ESG investorsWeekly Trade Summary & Stock Timing and Entry Methods - ulpravda.ru
Will bioAffinity Technologies Inc. Equity Warrant stock attract ESG investors2025 Fundamental Recap & Daily Chart Pattern Signals - ulpravda.ru
Is bioAffinity Technologies Inc. stock trading at a premium valuationJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - ulpravda.ru
How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peersFundamental Stock Analysis & Small Entry Cost Stocks - ulpravda.ru
bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung - TipRanks
bioAffinity Technologies Maintains CAP Accreditation - TradingView — Track All Markets
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation - Business Wire
2026 world cup star players explained: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2026 world cup usa national team round of 32 playmakers low block defense odds analysis preview - ulpravda.ru
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
bioAffinity Technologies Inc. (BIAF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 10.8% – Here’s What Happened - Defense World
bioAffinity Technologies (NASDAQ:BIAF) Stock Price Down 4.9% – Here’s What Happened - Defense World
What drives bioAffinity Technologies Inc Equity Warrant stock priceMarket Liquidity Analysis & High Yield Market Growth - earlytimes.in
Bearish Setup: Will bioAffinity Technologies Inc stock pay special dividendsCPI Data & Weekly Momentum Stock Picks - moha.gov.vn
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership By Investing.com - Investing.com Nigeria
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership - Investing.com
bioAffinity Updates Village Oaks Physician Succession Agreement - TipRanks
bioAffinity Technologies Announces Succession Agreement - TradingView — Track All Markets
Is bioAffinity Technologies Inc. stock a defensive play in 2025Trade Volume Summary & Community Trade Idea Sharing Platform - Улправда
Energy Moves: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Will bioAffinity Technologies Inc. stock return to pre crisis levelsJuly 2025 Setups & Free Long-Term Investment Growth Plans - Улправда
Nasdaq Moves: Why bioAffinity Technologies Inc. stock could be next big winnerQuarterly Trade Report & Community Verified Watchlist Alerts - moha.gov.vn
How bioAffinity Technologies Inc. Equity Warrant stock trades during market volatilityJuly 2025 Chart Watch & Free Verified High Yield Trade Plans - Улправда
bioAffinity Technologies Earnings Notes - Trefis
Will bioAffinity Technologies Inc. Equity Warrant stock deliver strong dividend growthWeekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Market Catalysts: Is bioAffinity Technologies Inc. stock a defensive play in 2025Weekly Investment Recap & Safe Investment Capital Preservation Plans - Улправда
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum - Investing.com Nigeria
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum By Investing.com - Investing.com South Africa
bioAffinity Technologies Adjourns Special Meeting - TradingView — Track All Markets
New Highs: Why bioAffinity Technologies Inc. stock could be next big winner - Улправда
Rate Hike: Can bioAffinity Technologies Inc. stock maintain growth trajectoryQuarterly Risk Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Is bioAffinity Technologies Inc. Equity Warrant stock dividend yield sustainablePortfolio Return Summary & Advanced Technical Analysis Signals - DonanımHaber
Trading Recap: Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growthInsider Buying & AI Forecasted Stock Moves - DonanımHaber
Why bioAffinity Technologies Inc. stock could be next big winnerWeekly Investment Report & Smart Investment Allocation Insights - Улправда
What catalysts could drive bioAffinity Technologies Inc. Equity Warrant stock higherJuly 2025 Movers & Daily Volume Surge Trade Alerts - Улправда
bioAffinity Technologies, Inc. (BIAFW) Fundamental Analysis - Meyka
Reviewing bioAffinity Technologies (NASDAQ:BIAF) and Briacell Therap (NASDAQ:BCTX) - Defense World
Why bioAffinity Technologies Inc. stock could outperform in 2025Trade Risk Assessment & Growth Oriented Trading Recommendations - Newser
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society - PharmiWeb.com
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable - BioSpace
bioAffinity Technologies to Present at Cancer Roundtable - TipRanks
bioAffinity Technologies, Inc. to Present CyPath® Lung Test at ACS Roundtable - TradingView
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):